| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Environmental Toxicology Center [D. L. A., S. E. E., C. R. J.] and Department of Pharmacology [C. R. J.], University of Wisconsin, Madison, Wisconsin 53705
Cytochrome P4501B1 is highly active in the bioactivation of polycyclic aromatic hydrocarbons (PAHs) to mutagenic metabolites. The C3H mouse embryo fibroblast cell line, C3H10T1/2, and primary mouse embryo fibroblasts (MEFs) express CYP1B1 as the predominant cytochrome P-450 form. This is constitutively expressed and induced by 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) but also, to a greater extent, by PAH. To establish the role of the aryl hydrocarbon receptor (AhR) in the induction responses to PAH and TCDD in MEFs, we measured CYP1B1 expression in primary MEFs generated from congenic C57b/6 mice that differ only at the AhR locus. These MEF cells express either b-1 or d-type Ah receptors, with high and low affinities for AhR agonists, respectively. Both types of MEFs express constitutive CYP1B1 to a similar extent, as measured by expression of mRNA, protein, and activity (PAH metabolism). Induction of CYP1B1 in responsive b-1 MEFs exhibited a 5-fold lower EC50 for TCDD, as compared with MEFs expressing d-type AhR. This is fully consistent with AhR mediation of the induction. Maximal induction of CYP1B1 by 10-8 M TCDD was comparable in each MEF type. Very low levels of CYP1A1 mRNA, detected by reverse transcriptase-PCR, show a similar dependence on AhR phenotype in these MEFs. The expression of CYP1B1 was highly dependent upon the passage number of the primary MEF cultures. Paralleling decreased proliferation of these cells after passage 7 are changes in cell morphology, the appearance of increasing numbers of differentiated cell types, and the complete loss of CYP1B1 expression. Colonies of these MEFs, which have escaped senescence, proliferate at much later passages, regain CYP1B1 expression, and exhibit the same AhR-dependent CYP1B1 induction responses, as observed in early-passage MEFs and the C3H10T1/2 cell line. We conclude that CYP1B1 expression, including induction via the AhR, parallels a proliferative state for MEF cells.
1 This work was supported by NIH Grant CA16265. This work was presented at the Annual Meeting of the Society of Toxicology, held March 59, 1995, in Seattle, WA, and at the 10th International Symposium on Microsomes and Drug Oxidations, held July 2124, 1994, in Toronto, Canada.
2 To whom requests for reprints should be addressed, at Department of Pharmacology, University of Wisconsin, 1300 University Avenue, Madison, Wisconsin 53705. Phone: (608) 263-3128; Fax: (608) 262-1257; E-mail: dalexanl@students.wisc.edu. Environmental Toxicology Center Publication No. 299.
Received 4/ 7/97. Accepted 8/13/97.
This article has been cited by other articles:
![]() |
H.-C. Yin, H.-P. Tseng, H.-Y. Chung, C.-Y. Ko, W.-S. Tzou, D. R. Buhler, and C.-H. Hu Influence of TCDD on Zebrafish CYP1B1 Transcription during Development Toxicol. Sci., May 1, 2008; 103(1): 158 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shin, N. Wakabayashi, V. Misra, S. Biswal, G. H. Lee, E. S. Agoston, M. Yamamoto, and T. W. Kensler NRF2 Modulates Aryl Hydrocarbon Receptor Signaling: Influence on Adipogenesis Mol. Cell. Biol., October 15, 2007; 27(20): 7188 - 7197. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kann, M.-y. Huang, C. Estes, J. F. Reichard, M. A. Sartor, Y. Xia, and A. Puga Arsenite-Induced Aryl Hydrocarbon Receptor Nuclear Translocation Results in Additive Induction of Phase I Genes and Synergistic Induction of Phase II Genes Mol. Pharmacol., August 1, 2005; 68(2): 336 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mador, E. Braun, H. Haim, I. Ariel, A. Panet, and I. Steiner Transgenic Mouse with the Herpes Simplex Virus Type 1 Latency-Associated Gene: Expression and Function of the Transgene J. Virol., December 1, 2003; 77(23): 12421 - 12429. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Locati, U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai, and A. Mantovani Analysis of the Gene Expression Profile Activated by the CC Chemokine Ligand 5/RANTES and by Lipopolysaccharide in Human Monocytes J. Immunol., April 1, 2002; 168(7): 3557 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Larsen-Su and D. E. Williams Transplacental Exposure to Indole-3-carbinol Induces Sex-Specific Expression of CYP1A1 and CYP1B1 in the Liver of Fischer 344 Neonatal Rats Toxicol. Sci., December 1, 2001; 64(2): 162 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Bofinger, L. Feng, L.-H. Chi, J. Love, F. D. Stephen, T. R. Sutter, K. G. Osteen, T. G. Costich, R. E. Batt, S. T. Koury, et al. Effect of TCDD Exposure on CYP1A1 and CYP1B1 Expression in Explant Cultures of Human Endometrium Toxicol. Sci., August 1, 2001; 62(2): 299 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Santiago-Josefat, E. Pozo-Guisado, S. Mulero-Navarro, and P. M. Fernandez-Salguero Proteasome Inhibition Induces Nuclear Translocation and Transcriptional Activation of the Dioxin Receptor in Mouse Embryo Primary Fibroblasts in the Absence of Xenobiotics Mol. Cell. Biol., March 1, 2001; 21(5): 1700 - 1709. [Abstract] [Full Text] |
||||
![]() |
J. K. Kerzee and K. S. Ramos Activation of c-Ha-ras by Benzo(a)pyrene in Vascular Smooth Muscle Cells Involves Redox Stress and Aryl Hydrocarbon Receptor Mol. Pharmacol., July 1, 2000; 58(1): 152 - 158. [Abstract] [Full Text] |
||||
![]() |
W. G.R. Angus, M. C. Larsen, and C. R. Jefcoate Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status Carcinogenesis, June 1, 1999; 20(6): 947 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. M. Buters, S. Sakai, T. Richter, T. Pineau, D. L. Alexander, U. Savas, J. Doehmer, J. M. Ward, C. R. Jefcoate, and F. J. Gonzalez Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas PNAS, March 2, 1999; 96(5): 1977 - 1982. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Heidel, C. J. Czuprynski, and C. R. Jefcoate Bone Marrow Stromal Cells Constitutively Express High Levels of Cytochrome P4501B1 that Metabolize 7,12-Dimethylbenz[a]anthracene Mol. Pharmacol., December 1, 1998; 54(6): 1000 - 1006. [Abstract] [Full Text] |
||||
![]() |
P. B. Brake, L. Zhang, and C. R. Jefcoate Aryl Hydrocarbon Receptor Regulation of Cytochrome P4501B1 in Rat Mammary Fibroblasts: Evidence for Transcriptional Repression by Glucocorticoids Mol. Pharmacol., November 1, 1998; 54(5): 825 - 833. [Abstract] [Full Text] |
||||
![]() |
L. Zhang, U. Savas, D. L. Alexander, and C. R. Jefcoate Characterization of the Mouse Cyp1B1 Gene. IDENTIFICATION OF AN ENHANCER REGION THAT DIRECTS ARYL HYDROCARBON RECEPTOR-MEDIATED CONSTITUTIVE AND INDUCED EXPRESSION J. Biol. Chem., February 27, 1998; 273(9): 5174 - 5183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Alexander, L. Ganem, P Fernandez-Salguero, F Gonzalez, and C. Jefcoate Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis J. Cell Sci., January 11, 1998; 111(22): 3311 - 3322. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |